Medicine recalls
|
| |
| Canada: Recall: ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised |
| |
Health Canada announces that Steri-Med Pharma Inc. is recalling one lot of Erythromycin Opthalmic Ointment USP (lot number: 2024L02) from retailers because the sterility of the product could be compromised in the affected lot.
The product is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin and for the prophylaxis of ophthalmic neonatorum due to N. gonorrhoeae or C. trachomatis.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/erythromycin-ophthalmic-ointment-usp-sterility-product-could-be-compromised
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 2 Dec 2025 and 24 Dec 2025.
Ends/Thursday, May 21, 2026
Issued at HKT 17:45
|
| |
